Biftek

Biftek is a technology company.

Active

Updated: Mar 20, 2026 ·

About

Biftek develops a microorganism-based growth medium supplement designed for the cultivated meat industry. Their proprietary formulation enables the growth of muscle stem cells without the need for genetic modification or antibiotics, presenting a cost-effective and natural solution for producing sustainable meat alternatives. This technical approach directly addresses one of the primary cost barriers in scaling cultivated meat production, offering a viable path to more affordable cell-based protein.

The company was co-founded by Prof. Dr. Can Akcali, Chief Scientific Officer, Dr. Erdem Erikçi, Chief Technology Officer, and Kerem Erikçi, Chief Executive Officer. Prof. Akcali, with an MD and a PhD in cellular and molecular biology, and Dr. Erikçi, holding degrees in molecular biology and genetics, provide the scientific backbone. Kerem Erikçi, with an electrical engineering background and an MBA, leads the business strategy. Their shared insight focused on innovating the high-cost growth media that limited the economic viability of cultivated meat.

Biftek primarily serves companies within the cultivated meat sector looking to enhance efficiency and reduce manufacturing expenses. The company's overarching vision is to accelerate the widespread adoption of sustainable and ethically produced meat options. By providing an accessible and animal-free growth medium, Biftek aims to make high-quality cultivated meat a mainstream reality, fostering a food system that better addresses both environmental impact and animal welfare.

Recent News & Mentions

Aug 1, 2020FundingBiftek - Seed

Financial History

Biftek has raised $400K across 1 funding round. Most recently, it raised $400K Seed in August 2020.

Total Raised

$400K

Valuation

N/A

Funding Rounds Raised

Date	Round	Lead Investors	Other Investors
Aug 1, 2020	$400K Seed		Big Idea Ventures, SOSV

Financial History

Biftek has raised $400K across 1 funding round.

Total Raised

$400K

Valuation

N/A

Deep Dive

# Biftek: Cultured Meat Growth Medium Pioneer

High-Level Overview

Biftek is a Turkish-US startup that produces microorganism-based growth medium supplements for the cultured meat industry.[4] The company addresses a critical cost barrier in cellular agriculture by replacing expensive fetal bovine serum (FBS) with an animal-free, bacteria-based alternative.[6] This innovation directly tackles affordability—a primary obstacle preventing cultured meat from scaling commercially. Biftek's mission centers on making sustainable protein production economically viable while eliminating the environmental and ethical costs of conventional meat production.[1][2]

The company serves cultured meat producers seeking to reduce production costs and improve sustainability metrics. By lowering the cost per kilogram of cultured meat through more affordable growth medium, Biftek enables the broader clean meat industry to approach price parity with conventional meat, potentially unlocking mass-market adoption.[1]

Core Differentiators

Novel substrate approach: Biftek's lyophilized, bacteria-based serum replaces FBS, which is both costly and ethically problematic, with a natural, microorganism-derived alternative.[6]

Cost reduction focus: The company explicitly targets the cost problem in cultured meat production, using "novel approaches" to ease economic barriers.[5]

Environmental credentials: Biftek's growth medium eliminates the need for animal inputs, reducing water consumption, land use, and greenhouse gas emissions in meat production.[1]

Natural formulation: The product contains no genetic modifications or antibiotics, positioning cultured meat as a cleaner alternative to both conventional and some biotech-heavy approaches.[1]

Role in the Broader Tech Landscape

Biftek operates at the intersection of cellular agriculture and biotech innovation, riding the wave of cultured meat commercialization. The timing is critical: as regulatory pathways open globally and consumer acceptance grows, the industry faces a profitability crunch. Growth medium costs represent one of the largest expense categories in cultured meat production, making Biftek's solution strategically important to the sector's viability.

The company influences the ecosystem by demonstrating that ingredient-level innovation—rather than only cell line or bioreactor advances—can unlock scalability. By solving a supply-chain problem rather than reinventing the core technology, Biftek enables other cultured meat producers to focus on differentiation and scale.

Quick Take & Future Outlook

Biftek's success hinges on two factors: achieving cost parity with FBS while maintaining product quality, and securing partnerships with cultured meat producers moving toward commercialization. As the cultured meat industry matures from R&D to production, companies like Biftek that solve infrastructure and cost challenges will become increasingly valuable.

The broader trajectory suggests Biftek could evolve from a niche supplier into a critical enabler of cultured meat's mainstream adoption—positioning the company as essential infrastructure in the protein transition.

Sources

Frequently Asked Questions

How much funding has Biftek raised?

Biftek has raised $400K in total across 1 funding round.

Who are Biftek's investors?

Biftek's investors include Big Idea Ventures, SOSV.